Mostrar el registro sencillo del ítem
dc.contributor.author
Venzon Antunes, Marina
dc.contributor.author
Linden, Rafael
dc.contributor.author
Schaiquevich, Paula Susana
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.date.available
2022-08-02T16:58:07Z
dc.date.issued
2021-01
dc.identifier.citation
Venzon Antunes, Marina; Linden, Rafael; Schaiquevich, Paula Susana; Therapeutic drug monitoring in developing nations: Assessing the current state of affairs in South America; Taylor & Francis; Expert Opinion on Drug Metabolism & Toxicology; 17; 3; 1-2021; 251-254
dc.identifier.issn
1742-5255
dc.identifier.uri
http://hdl.handle.net/11336/163919
dc.description.abstract
Therapeutic drug monitoring (TDM) aims to offer assistance to clinicians to improve drug dosing and clinical outcomes, while minimizing the probability of serious adverse effects in routine clinical practice. Disease conditions, drug-drug and drug-herbal interactions, noncompliance, and genetic features affect the relationship between drug concentrations in the body and clinical effects. They contribute to the pharmacokinetic inter-patient variability which ultimately impactsdrug response, resulting in some patients showing lack of therapeutic effects while others experience toxicity. Thus, the identification of the sources of pharmacokinetic variability contributes to the adequacy of the dosing regimen [1]. However, performing TDM in Developing Nations as South American Countries is particularly challenging, mainly due to the lack of structure and economic aspects.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Taylor & Francis
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
DEVELOPING NATION
dc.subject
PHARMACOGENETIC
dc.subject
SOUTH AMERICA
dc.subject
THERAPEUTIC DRUG MONITORING
dc.subject.classification
Otras Medicina Clínica
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Medicina Clínica
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Therapeutic drug monitoring in developing nations: Assessing the current state of affairs in South America
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2022-08-01T13:40:53Z
dc.journal.volume
17
dc.journal.number
3
dc.journal.pagination
251-254
dc.journal.pais
Reino Unido
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.journal.ciudad
London
dc.description.fil
Fil: Venzon Antunes, Marina. Universidade Feevale; Brasil
dc.description.fil
Fil: Linden, Rafael. Universidade Feevale; Brasil
dc.description.fil
Fil: Schaiquevich, Paula Susana. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Gobierno de la Ciudad de Buenos Aires. Hospital de Pediatría "Juan P. Garrahan"; Argentina
dc.journal.title
Expert Opinion on Drug Metabolism & Toxicology
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/17425255.2021.1859478
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1859478
Archivos asociados